
Girumsew Wendmagegn
Examiner (ID: 176, Phone: (571)270-1118 , Office: P/2484 )
| Most Active Art Unit | 2484 |
| Art Unit(s) | 2621, 2484 |
| Total Applications | 1118 |
| Issued Applications | 807 |
| Pending Applications | 62 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9450069
[patent_doc_number] => 20140121239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'METHOD OF TREATING LUNG ADENOCARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 14/021614
[patent_app_country] => US
[patent_app_date] => 2013-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13243
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14021614
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/021614 | METHOD OF TREATING LUNG ADENOCARCINOMA | Sep 8, 2013 | Abandoned |
Array
(
[id] => 14169413
[patent_doc_number] => 10258693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Solid dosage formulations of narcotic drugs having improved buccal adsorption
[patent_app_type] => utility
[patent_app_number] => 14/017642
[patent_app_country] => US
[patent_app_date] => 2013-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1104
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14017642
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/017642 | Solid dosage formulations of narcotic drugs having improved buccal adsorption | Sep 3, 2013 | Issued |
Array
(
[id] => 9817821
[patent_doc_number] => 08927607
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-01-06
[patent_title] => 'Methods of colchicine administration'
[patent_app_type] => utility
[patent_app_number] => 13/973897
[patent_app_country] => US
[patent_app_date] => 2013-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 10545
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13973897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/973897 | Methods of colchicine administration | Aug 21, 2013 | Issued |
Array
(
[id] => 9198869
[patent_doc_number] => 20130338184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => '2-AMINO-NAPHTHYRIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/973810
[patent_app_country] => US
[patent_app_date] => 2013-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12362
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13973810
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/973810 | 2-AMINO-NAPHTHYRIDINE DERIVATIVES | Aug 21, 2013 | Abandoned |
Array
(
[id] => 10870413
[patent_doc_number] => 08895611
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-11-25
[patent_title] => 'Cytotoxic compounds for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 13/944761
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 5231
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944761
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/944761 | Cytotoxic compounds for treating cancer | Jul 16, 2013 | Issued |
Array
(
[id] => 9319380
[patent_doc_number] => 20140051718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'Compositions and Methods Comprising Celecoxib or Related Compounds and Dextromethorphan'
[patent_app_type] => utility
[patent_app_number] => 13/943729
[patent_app_country] => US
[patent_app_date] => 2013-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7314
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943729
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/943729 | Compositions and Methods Comprising Celecoxib or Related Compounds and Dextromethorphan | Jul 15, 2013 | Abandoned |
Array
(
[id] => 15068357
[patent_doc_number] => 10463644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation
[patent_app_type] => utility
[patent_app_number] => 15/110592
[patent_app_country] => US
[patent_app_date] => 2013-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13623
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110592 | Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation | Jul 14, 2013 | Issued |
Array
(
[id] => 15571461
[patent_doc_number] => 10576089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
[patent_app_type] => utility
[patent_app_number] => 13/936036
[patent_app_country] => US
[patent_app_date] => 2013-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 25483
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13936036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/936036 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | Jul 4, 2013 | Issued |
Array
(
[id] => 10968289
[patent_doc_number] => 20140371322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'Phenoxybenzamine Transdermal Composition'
[patent_app_type] => utility
[patent_app_number] => 13/917292
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6973
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917292
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/917292 | Phenoxybenzamine Transdermal Composition | Jun 12, 2013 | Abandoned |
Array
(
[id] => 9095010
[patent_doc_number] => 20130274321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'Topical Compositions with Cannabis Extracts'
[patent_app_type] => utility
[patent_app_number] => 13/912268
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6721
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13912268
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/912268 | Topical Compositions with Cannabis Extracts | Jun 6, 2013 | Abandoned |
Array
(
[id] => 10947095
[patent_doc_number] => 20140350117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'Topical Scar Treatment Composition and Method of Using Same'
[patent_app_type] => utility
[patent_app_number] => 13/900379
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4206
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900379
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900379 | Topical Scar Treatment Composition and Method of Using Same | May 21, 2013 | Abandoned |
Array
(
[id] => 9094971
[patent_doc_number] => 20130274282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'COMPOSITIONS AND METHODS COMPRISING CELECOXIB OR RELATED COMPOUNDS AND DEXTROMETHORPHAN'
[patent_app_type] => utility
[patent_app_number] => 13/857017
[patent_app_country] => US
[patent_app_date] => 2013-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7215
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857017
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/857017 | COMPOSITIONS AND METHODS COMPRISING CELECOXIB OR RELATED COMPOUNDS AND DEXTROMETHORPHAN | Apr 3, 2013 | Abandoned |
Array
(
[id] => 9448914
[patent_doc_number] => 20140120083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/840822
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 79574
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13840822
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/840822 | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9148972
[patent_doc_number] => 20130303495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'EMULSION FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/843223
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 37949
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843223
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/843223 | EMULSION FORMULATIONS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9042437
[patent_doc_number] => 20130245075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'MELANOGENESIS INHIBITION-METHODS AND COMPOSITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/834188
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 836
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13834188
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/834188 | MELANOGENESIS INHIBITION-METHODS AND COMPOSITIONS THEREOF | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9409024
[patent_doc_number] => 20140100277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'SOLUTIONS AND METHODS OF MAKING SOLUTIONS TO KILL OR DEACTIVATE SPORES, MICROORGANISMS, BACTERIA AND FUNGUS'
[patent_app_type] => utility
[patent_app_number] => 13/842574
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4637
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13842574
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/842574 | SOLUTIONS AND METHODS OF MAKING SOLUTIONS TO KILL OR DEACTIVATE SPORES, MICROORGANISMS, BACTERIA AND FUNGUS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 10187530
[patent_doc_number] => 09216942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-22
[patent_title] => 'Compounds and uses thereof for treating inflammation and modulating immune responses'
[patent_app_type] => utility
[patent_app_number] => 13/790707
[patent_app_country] => US
[patent_app_date] => 2013-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 9310
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13790707
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/790707 | Compounds and uses thereof for treating inflammation and modulating immune responses | Mar 7, 2013 | Issued |
Array
(
[id] => 10121388
[patent_doc_number] => 09155734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Stability of hydromorphone hydrochloride solutions'
[patent_app_type] => utility
[patent_app_number] => 13/787042
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2900
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13787042
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/787042 | Stability of hydromorphone hydrochloride solutions | Mar 5, 2013 | Issued |
Array
(
[id] => 9817801
[patent_doc_number] => 08927586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Thromboxane A2 (TP) receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 13/780458
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 38722
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13780458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/780458 | Thromboxane A2 (TP) receptor antagonists | Feb 27, 2013 | Issued |
Array
(
[id] => 9042451
[patent_doc_number] => 20130245089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'METHOD FOR ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 13/759647
[patent_app_country] => US
[patent_app_date] => 2013-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3235
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13759647
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/759647 | METHOD FOR ADMINISTRATION | Feb 4, 2013 | Abandoned |